Javanshir H, Malekraeisi M, Ebrahimi S, Bereimipour A, Kashani S, Bostaki A
J Med Life. 2022; 15(9):1143-1157.
PMID: 36415513
PMC: 9635241.
DOI: 10.25122/jml-2022-0067.
McInnes A, Moser M, Chen X
J Funct Biomater. 2022; 13(4).
PMID: 36412881
PMC: 9680265.
DOI: 10.3390/jfb13040240.
Bawazeer S, Sabry D, Mahmoud R, Elhanbuli H, Yassen N, AbdelHafez M
Mol Biol Rep. 2018; 45(6):2313-2324.
PMID: 30259245
DOI: 10.1007/s11033-018-4394-2.
Iwasa M, Miura Y, Fujishiro A, Fujii S, Sugino N, Yoshioka S
Int J Hematol. 2017; 105(5):587-597.
PMID: 28044259
DOI: 10.1007/s12185-016-2169-x.
Jiang Y, Zhu Y, Shi Y, He Y, Kuang Z, Sun Z
PLoS One. 2013; 8(7):e69079.
PMID: 23935929
PMC: 3720866.
DOI: 10.1371/journal.pone.0069079.
Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis.
Azim Jr H, Singhal S, Ignatiadis M, Desmedt C, Fumagalli D, Veys I
PLoS One. 2013; 8(4):e62451.
PMID: 23638089
PMC: 3637211.
DOI: 10.1371/journal.pone.0062451.
Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells.
Goh T, Zhang Z, Chen A, Reuveny S, Choolani M, Yen Chan J
Biores Open Access. 2013; 2(2):84-97.
PMID: 23593561
PMC: 3620494.
DOI: 10.1089/biores.2013.0001.
Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.
Nde P, Lima M, Johnson C, Pratap S, Villalta F
Front Immunol. 2012; 3:337.
PMID: 23133440
PMC: 3490126.
DOI: 10.3389/fimmu.2012.00337.
Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.
Johnson C, Kleshchenko Y, Ikejiani A, Udoko A, Cardenas T, Pratap S
PLoS One. 2012; 7(7):e40614.
PMID: 22808206
PMC: 3394756.
DOI: 10.1371/journal.pone.0040614.
Insights into the role of focal adhesion modulation in myogenic differentiation of human mesenchymal stem cells.
Yu H, Lui Y, Xiong S, Leong W, Wen F, Nurkahfianto H
Stem Cells Dev. 2012; 22(1):136-47.
PMID: 22765653
PMC: 3528092.
DOI: 10.1089/scd.2012.0160.
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
Arnold S, Rivera L, Carbon J, Toombs J, Chang C, Bradshaw A
PLoS One. 2012; 7(2):e31384.
PMID: 22348081
PMC: 3279359.
DOI: 10.1371/journal.pone.0031384.
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.
Arnold S, Rivera L, Miller A, Carbon J, Dineen S, Xie Y
Dis Model Mech. 2009; 3(1-2):57-72.
PMID: 20007485
PMC: 2806901.
DOI: 10.1242/dmm.003228.
SPARC: a matricellular regulator of tumorigenesis.
Arnold S, Brekken R
J Cell Commun Signal. 2009; 3(3-4):255-73.
PMID: 19809893
PMC: 2778590.
DOI: 10.1007/s12079-009-0072-4.
Matricellular proteins: an overview.
Bornstein P
J Cell Commun Signal. 2009; 3(3-4):163-5.
PMID: 19779848
PMC: 2778588.
DOI: 10.1007/s12079-009-0069-z.
Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.
Arnold S, Mira E, Muneer S, Korpanty G, Beck A, Holloway S
Exp Biol Med (Maywood). 2008; 233(7):860-73.
PMID: 18445772
PMC: 2459223.
DOI: 10.3181/0801-RM-12.
